domperidone has been researched along with Flatulence in 2 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
Flatulence: Production or presence of gas in the gastrointestinal tract which may be expelled through the anus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Domperidone was taken at a dosage of 10 mg tablets 4-times daily." | 2.65 | Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome. ( Milo, R, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksseva, EV | 1 |
| Fominykh, VP | 1 |
| Tropskaia, NS | 1 |
| Popova, TS | 1 |
| Milo, R | 1 |
1 trial available for domperidone and Flatulence
| Article | Year |
|---|---|
Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome.
Topics: Abdomen; Adult; Aged; Benzimidazoles; Clinical Trials as Topic; Colonic Diseases, Functional; Defeca | 1980 |
1 other study available for domperidone and Flatulence
| Article | Year |
|---|---|
[Use of the prokinetic domperidine in patients in the early postoperative period].
Topics: Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fema | 2010 |